We believe that partnership is a important part of project success. SDS Optic recognize and value that collaboratively work can help us to improve our vision. We cooperate with experienced scientists, doctors, bio tech engineers and business specialists.The partnerships formed between interested science and medical institutions advance our mission and allow to make another step to future.

Warsaw University of Technology, Institute of Microelectronics and Optoelectronics

WARSAW UNIVERSITY OF TECHNOLOGY (WUT) is ranked as No. 1 among technical universities in Poland. There are 19 faculties, 2500 employed scientists, and over 33,000 students. Warsaw University of Technology builds upon the traditions of Polish technical universities that used to function in Warsaw. The Polytechnic Institute founded in 1826 thanks to the efforts of Stanisław Staszic and the School of Hipolit Wawelberg and Stanisław Rotwand established in 1895. Warsaw University of Technology started on its own in 1915 thanks to the efforts of the Association for Scientific Courses and the Citizens’ Committee of the City of Warsaw. Working uninterruptedly, the University has been producing generations of graduates and has had an increasing number of scientific and technical achievements. It is not only the oldest, but also the best technical university in Poland; in the ranking of Polish universities, it has taken the first place in its category for nine years. At Warsaw University of Technology, over 180 student research groups, organizations and associations are active, and the educational offer includes more than 30 fields of study (also with English as a medium of instruction).

Visit official website:

PORT Polish Center for Technology Development (former EIT+), Nanobioengeenering Laboratory

PORT Polish Center for Technology Development is a research and development organization focused on the development of new technologies by conducting research for the needs and in cooperation with the industry. PORT is a network of specialized scientific-research and technological laboratories as well as measurement and specialist laboratories, which are clustered in 6 research areas: biobank, biotechnology, nanobioengineering, special materials, photonics and electronics, analytics. Each of the areas brings together several specialized laboratories; thanks to this, a given area can focus on selected scientific and technological issues and carry out both scientific and research work as well as pilot research for industry in a comprehensive way. All laboratories of the PORT Polish Center for Technology Development are equipped with the highest-class research equipment which allows conducting application research while maintaining the highest quality standards.

Visit official website:

Clinmark CRO

Leading Polish Contract Research Organization. Clinmark conducts the full scope of operational activities in clinical research, professional consulting and education. Clinmark has operated since 2001 in Poland and other CEE markets. Clinmark has conducted more than 150 research projects in almost any therapeutical area. 8 out of top 10 worldwide pharmaceutical companies are their clients.

Visit official website:

Medical University of Lublin

The Medical University of Lublin was formed by the Cabinet’s decree on 24 October 1949. It conducts research tasks, educates students and doctoral candidates in the field of medical, pharmaceutical and health sciences. Moreover the University participates in exercising the medical care on the basis of self-contained public healthcare centers. The Medical University of Lublin is divided into four faculties: I Faculty of Medicine with Dentistry Division, II Faculty of Medicine with English Language Division, Faculty of Pharmacy with Medical Analytics Division and Faculty of Nursing and Health Sciences. Currently, almost 7.000 people, over 1.000 of whom are foreign students from as many as 53 countries, are enrolled on degree courses.

Visit official website:

University of Life Sciences in Lublin

The University of Life Sciences in Lublin is a multi-profile higher education institution, which integrates a wide range of agricultural, biological, veterinary, technical and socioeconomic sciences. Educational offer is attractive for the local secondary school leavers as new directions of studies are created to meet requirements of the current job market in Poland, the contents and forms of education comply with current educational standards. Well experienced academic staff and up-to-date didactic and research base guarantee high level of education approved by certificates.The 65-year-old activity of the University has shown its high rank in the structure of the Polish higher education system.

Visit official website:

Wroclaw Medical University

Wroclaw Medical University is currently the largest in Lower Silesian Voivodeship with over 100,000 graduates since 1945 including some 1,900 researchers among whom many received the highest awards for their contribution to the development of scientific scholarship.The University of Wrocław is renowned for its relatively high quality of teaching, placing 44th on the QS University Rankings: EECA 2016,and is located in the same campus as the former University of Breslau, which produced 9 Nobel Prize winners.

Visit official website:

Institute of Immunology and Experimental Therapy

Institute of Immunology and Experimental Therapy was founded in 1952 by the Polish Academy of Sciences. The main founder and the first director of the Institute was Professor Ludwik Hirszfeld, famous Polish immunologist and microbiologist.

Visit official website:

Lublin Medicine Cluster

Lublin Medicine – Medical & Wellness Cluster is a cooperation platform among higher education institutions, research centers, healthcare entities, entrepreneurs, institutions for collaboration and local authorities, Cluster was established in January 2014 by representatives of the City of Lublin and Medical University of Lublin. The aim of this initiative is to support local medical and wellness industries development.

Visit official website:

Amazonki Polish Foundation Against Breast Cancer

Amazonki mission is to help women now by providing help and inspiring hope to those affected by breast cancer through early detection, education and support services.

Visit official site:

Rak’n’Roll Foundation

Avon Against Breast

Our vision

Save 30% of people deadly sick with cancer by 2030

Our vision is to develop innovative cancer diagnostics & monitoring technologies which will help increase cancer survival by 30% by 2030. We will achieve that by implementing real-time, in vivo (closest possible to disease condition) and numerical based technologies. 

Strategy and mission

Our strategy is to discover, develop, produce and commercialize on a global scale unique innovative diagnostics and monitoring technologies working in real-time and in a natural state, which support and save Lifes.We respond to people living with serious cancer, autoimmune and dangerous fungal diseases as well as rare infectious conditions.We concentrate on helping the healthcare with faster, less painful diagnostics and supporting targeted, effective treatment procedures. Working with key collaborators we seek to develop and create high value applications that can bring innovative medicines to more people much faster, leading to improvements in health and longer lifetimes worldwide. SDS Optic’s mission is to create life saving innovations

Who we are

SDS Optic develops and creates innovative solutions on the borderline of biochemistry, engineering and fibre optic technologies, that can be used in cancer diagnosis and treatment. Company designed a revolutionary opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. inPROBE detects presence and measures concentration levels of the HER+ cancer cells in breast tumours. It is a breakthrough device that carries the potential to address the challenges of SoA cancer markers diagnosis and biopsies. In essence, it is a laboratory test at the tip of a probe, but with greater accuracy, efficacy and quantitative results. SDS-OmiProbe may also be used as a companion diagnostic tool for targeted therapy and targeted therapy drugs.Additionally company was granted €3.985.000 from the SME Instrument (Horizon 2020) programme to develop a revolutionary optical device OmiProbe for safe, fast and non-destructive cancer diagnosis.

New Technology

Our technology is a breakthrough. We create a tool for direct measurement of the HER2 marker. The use of a microsonde will save the patient pain and stress associated with biopsy and waiting for the result – says Marcin Staniszewski, President of the Board of SDS Optic and the originator of the microscope, a graduate of the University of Akron and a collaborator of NASA Laboratory.


Our vision is to make widespread use of our technology to diagnose breast cancer. According to WHO analyses, a fast and effective cancer diagnosis can lead to a reduction in mortality of up to 30%. The problem affects hundreds of thousands of women around the world, who thanks to our technology will receive reliable and fast diagnosis and better chances for curing – adds Magdalena Staniszewska, PhD, Chief Science Officer of SDS Optic and the originator of the microscope, for many years associated with Harvard Medical School in Boston.

Research and innovations

The research and development centre opened on 19 April will allow intensifying the work of SDS Optic on a globally unique technology of in vivo diagnostics, directly in the patient’s body. The laboratory is divided into three areas, each of which will have a qualified team of biologists, chemists, biomedical engineers and physicists. The company is in the process of developing its interdisciplinary team, and scientists who join the group often return from abroad, including the UK and Italy.

Thanks to the support we received from our Investor, we managed to purchase professional and modern laboratory equipment, which includes, among others a chromatograph and ChemicalDoc system for gel imaging and analysis from Bio-Rad, an advanced spectrophotometer, Nikon’s flagship model of fluorescence microscope, and a range of basic equipment and accessories for a modern laboratory, including a professional system for low temperature storage of cells and tissues, incubators, autoclaves, fume cupboards, centrifuges and shakers. Thanks to such professional equipment of our laboratory we will be able to carry out further stages of work and develop our crucial technology on our own. A laboratory, with such equipment and opportunities concerning development, including business from the first days of its operation, is a certain asset for our shareholders – describes Mateusz Sagan, Director of Development and Member of the Supervisory Board of SDS Optic.

Revolution in world oncology diagnostic

The SDS Optic team is working on a breakthrough technology based on rapid detection of the test substance in the body, including cancer markers, with particular accuracy, the use of laser beams and the use of innovative components. At the end of the process, the reading is interpreted on the detector using an appropriate conversion algorithm, which gives the level of the tested compound (e.g. HER2 cancer marker) in a numerical form. Due to the high sensitivity of detection, it will not be necessary to measure the markers inside the tumour tissue itself, but in its vicinity.

Thanks to the use of a thin microsound, the device is to perform accurate, very fast and less painful measurement of tumour markers. Currently, SDS Optic focuses on breast cancer, with particular emphasis on the measurement of the HER2 and CCL markers.5 Such diagnosis will allow physicians to start a therapy suitable for the patient much faster, which in turn will translate into the effectiveness of the treatment process.

European grants winner

The development of innovative technology for the production of laser microsomes is possible thanks to the significant support of SDS Optic from public funds. The National Centre for Research and Development co-financed the project under the STRATEGMED and PatentPlus programmes. INNOventure also invested PLN 3 million in the development of SDS Optic, a fund of the Kraków Technology Park and private investors established as part of the initiative of NCBiR – BRIdge Alfa.

Programmes implemented by the National Centre for Research and Development are an excellent example of cooperation between state institutions, scientists and entrepreneurs. In the case of BRIdge Alfa, thanks to the use of private and public capital, as well as the knowledge of professional management teams, we can search for and support projects which today are carried out in intimate academic environments, and tomorrow have a chance to become Polish unicorns – says Prof. Aleksander Nawrat, Deputy Director of the National Centre for Research and Development.

SDS Optic is also one of the largest beneficiaries of the SME Facility under the “Horizon 2020” programme of the European Commission and a member of the “Lublin Medicine Cluster”.